Release Date: 21/11/14 20:20 Summary: Share Purchase Plan Withdrawn Price Sensitive: Yes Download Document 356.78KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%